Apr 20, 2025, 19:06

ACS IMPACT – Expanding Prostate Cancer Clinical Trials in the Community

The ACS IMPACT grant supports local oncology practices and hospitals in expanding clinical trial enrollment among Black men with prostate cancer. This initiative addresses the most significant mortality disparity in oncology and aims to enhance racial diversity in prostate cancer trials through targeted infrastructure support and partnerships with the Prostate Cancer Clinical Trials Consortium (PCCTC) and Trial Library.

Eligibility

Must have direct patient interaction and the ability to participate in clinical trials
Sites affiliated with an NCI-designated comprehensive cancer center must clearly justify how they will engage community practices and improve diversity
Institutions must be able to implement clinical infrastructure and community engagement efforts

Grant Term and Budget

Up to 200,000 USD/year in direct costs
Up to 2 years of funding with a potential 1-year extension based on demonstrated progress
Funds may support clinical staff, recruitment activities, and infrastructure to engage prostate cancer patients

Important Dates

Informational Webinar: September 16, 2024, 12–1 PM ET
LOI Deadline: September 30, 2024
Application Deadline: January 15, 2025
Anticipated Start Date: April 1, 2025

(If a deadline falls on a weekend or holiday, submissions are accepted the next business day)

ACS IMPACT American Cancer Society Black men in oncology cancer Cancer Health Disparities clinical research diversity clinical trials OncoDaily Oncology PCCTC prostate cancer prostate cancer mortality Trial Library

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Yüksel Ürün: Science Is Better When It’s Shared